Gilead Sciences and ViiV Healthcare are locked in a standoff over HIV advertising claims, and the prevailing ad industry mediating organization is closing its case and passing the dispute along to the FDA and FTC for review.
Gilead initially lodged a complaint about ViiV’s Dovato ads claims with the Better…
